(MedPage Today) — A novel gene therapy enabled children with congenital deafness due to otoferlin (OTOF) gene variants to hear for the first time, the pivotal phase I/II CHORD study showed.
Of 12 such children treated with a single infusion of…
Source link : https://www.medpagetoday.com/neurology/generalneurology/117935
Author :
Publish date : 2025-10-14 15:07:00
Copyright for syndicated content belongs to the linked Source.
